Synthesis, characterization, and efficacy of antituberculosis isoniazid zinc aluminum-layered double hydroxide based nanocomposites

References

• Unaids WHOGTPAPolicy statement on preventive therapy against tuberculosis in people living with HIVPresented at: World Health Organization Global Tuberculosis Programme and UNAIDSFebruary 18–20, 1998Geneva
   Google Scholar
• SumartojoEWhen tuberculosis treatment fails. A social behavioral account of patient adherenceAm Rev Respir Dis19931475131113208484650
   PubMedGoogle Scholar
• CuneoWDSniderDEJrEnhancing patient compliance with tuberculosis therapyClin Chest Med19891033753802673646
   PubMed Web of Science ®Google Scholar
• WHOGuidelines for the Programmatic Management of Drug-Resistant TuberculosisGenevaWorld Health Organization201144
   Google Scholar
• HasanSAl AliHAl-QubaisiMControlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cellsInt J Nanomedicine201273351336322848164
   PubMed Web of Science ®Google Scholar
• WHOGlobal Tuberculosis ReportGenevaWorld Health Organization2014
   Google Scholar
• SharmaSKMohanAExtrapulmonary tuberculosisIndian J Med Res2004120431635315520485
   PubMed Web of Science ®Google Scholar
• AgarwalSGuptaMChoudhuryBSolvent free biocatalytic synthesis of isoniazid from isonicotinamide using whole cell of Bacillus smithii strain IITR6b2J Mol Catal B: Enzym2013976773
   Google Scholar
• Campos-FrancoJGonzalez-QuintelaAAlende-SixtoMRIsoniazid-induced hyperacute liver failure in a young patient receiving carbamazepineEur J Intern Med200415639639715522577
   PubMedGoogle Scholar
• VidrioHMedinaMFernándezGLorenzana-JiménezMCamposAEEnhancement of hydralazine hypotension by low doses of isoniazid: Possible role of semicarbazide-sensitive amine oxidase inhibitionGen Pharmacol200035419520411827726
   PubMedGoogle Scholar
• TafazoliSMashregiMO’brienPJRole of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation modelToxicol Appl Pharmacol200822919410118295292
   PubMed Web of Science ®Google Scholar
• Van HestRBaarsHKikSHepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatmentClin Infect Dis200439448849615356811
   PubMed Web of Science ®Google Scholar
• GuptaAKaulATsolakiAGKishoreUBhaktaSMycobacterium tuberculosis: immune evasion, latency and reactivationImmunobiology2012217336337421813205
   PubMed Web of Science ®Google Scholar
• SaifullahBHusseinMZHussein Al AliSHControlled-release approaches towards the chemotherapy of tuberculosisInt J Nanomedicine201275451546323091386
   PubMed Web of Science ®Google Scholar
• ClemensDLLeeBYXueMTargeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticlesAntimicrob Agents Chemother20125652535254522354311
   PubMed Web of Science ®Google Scholar
• BermudezLEGoodmanJMycobacterium tuberculosis invades and replicates within type II alveolar cellsInfect Immun1996644140014068606107
   PubMed Web of Science ®Google Scholar
• FlynnJLChanJImmune evasion by Mycobacterium tuberculosis: living with the enemyCurr Opin Immunol200315445045512900278
   PubMed Web of Science ®Google Scholar
• ChenHWangLYehJReducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coatingBiomaterials201031205397540720398933
   PubMed Web of Science ®Google Scholar
• HeQZhangZGaoFLiYShiJIn vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylationSmall20117227128021213393
   PubMed Web of Science ®Google Scholar
• AnisimovaYVGelperinaSIPeloquinCAHeifetsLBNanoparticles as antituberculosis drugs carriers: Effect on activity against mycobacterium tuberculosis in human monocyte-derived macrophagesJ Nanopart Res200022165171
   Web of Science ®Google Scholar
• SaifullahBHusseinMZHussein-Al-AliSHArulselvanPFakuraziSSustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocompositeChem Cent J2013717223601852
   PubMedGoogle Scholar
• SaifullahBHusseinMZHussein-Al-AliSHArulselvanPFakuraziSAntituberculosis nanodelivery system with controlled-release properties based on para-amino salicylate-zinc aluminum-layered double-hydroxide nanocompositesDrug Des Devel Ther2013713651375
   PubMed Web of Science ®Google Scholar
• Del HoyoCLayered double hydroxides and human health: An overviewAppl Clay Sci2007361–3103121
   Web of Science ®Google Scholar
• CavaniFTrifiròFVaccariAHydrotalcite-type anionic clays: Preparation, properties and applicationsCatal Today1991112173301
   Web of Science ®Google Scholar
• SaifullahBHusseinMZInorganic nanolayers: structure, preparation, and biomedical applicationsIJNM20151024
   Google Scholar
• RivesVDel ArcoMMartínCLayered double hydroxides as drug carriers and for controlled release of non-steroidal antiinflammatory drugs (NSAIDs): a reviewJ Control Release20131691–2283923583707
   PubMed Web of Science ®Google Scholar
• RivesVDel ArcoMMartínCIntercalation of drugs in layered double hydroxides and their controlled release: A reviewAppl Clay Sci20148889239269
   Web of Science ®Google Scholar
• NewmanSPJonesWSynthesis, characterization and applications of layered double hydroxides containing organic guestsNew J Chem1998222105115
   Web of Science ®Google Scholar
• DhalSKSharmaRDevelopment and Validation of RP-HPLC Method for Simultaneous Determination of Pyridoxine Hydrochloride, Isoni-azid, Pyrazinamide and Rifampicin in pharmaceutical FormulationWarszawaInstytut Chemii Fizycznej, POLOGNE542009
   Google Scholar
• KongXShiSHanJZhuFWeiMDuanXPreparation of Glycy-l-Tyrosine intercalated layered double hydroxide film and its in vitro release behaviorChem Eng J20101572–3598604
   Web of Science ®Google Scholar
• HoYSOfomajaAEPseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fiberJ Hazard Mater20061291–313714216188379
   PubMed Web of Science ®Google Scholar
• WaltersSBHannaBATesting of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube methodJ Clin Microbiol1996346156515678735121
   PubMed Web of Science ®Google Scholar
• HusainAAmide derivatives of sulfonamides and isoniazid: synthesis and biological evaluationActa Pol Pharm200966551352119894647
   PubMed Web of Science ®Google Scholar
• GunasekaranSSSeshadriEKumaresanSFTIR, FT Raman spectra and molecular structural confirmation of isoniazidIJPAP20094715
   Web of Science ®Google Scholar
• RojasRPalenaMCJimenez-KairuzAFManzoRHGiacomelliCEModeling drug release from a layered double hydroxide–ibuprofen complexAppl Clay Sci201262631520
   Web of Science ®Google Scholar
• ParelloMLRojasRGiacomelliCEDissolution kinetics and mechanism of Mg–Al layered double hydroxides: A simple approach to describe drug release in acid mediaJ Colloid Interface Sci2010351113413920709325
   PubMed Web of Science ®Google Scholar
• PalaciMUekiSYSatoDNDa Silva TellesMACurcioMSilvaEAEvaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimensJ Clin Microbiol19963437627648904457
   PubMed Web of Science ®Google Scholar
• WenCCChenHMChenSSSpecific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccinesJ Biomed Sci2011184421689407
   PubMed Web of Science ®Google Scholar